PRESS RELEASES

08 March |  2021

Prilenia to Present at Upcoming Virtual Healthcare Conferences 

[Naarden, NL, 8 March 2021]  – Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that Dr Michael R. Hayden, MD, PhD Chief Executive Officer, will present at the following conferences in March:

  • H.C. Wainwright Global Life Sciences Conference, 9–10 March. The presentation will be available on-demand through the H.C. Wainwright conference portal. Registration Link: click here  

  • AD/PD: Alzheimer's & Parkinson's Diseases Conference, 9–14 March. The presentation will be available on-demand for registered participants in the AD/PD Meeting platform. Registration Link: click here 

Contacts:
Prilenia Therapeutics

Limor Ben Har, COO
E: info@prilenia.com

Instinctif Partners
Melanie Toyne-Sewell / Agnes Stephens / Siobhan Sanford
T: +44 (0) 207 457 2020
E: prilenia@instinctif.com